…computational approaches such as molecular dynamics. We have recently developed a new approach for extracting molecular, domain, secondary structure, and atomic motions from the disorder in macromolecular structures. This makes…
…Du LM, Bäcke O, Kalbfleisch S, Zhang GQ, Vollebregt S, Colliander MH Measuring residual stresses in individual on-chip interconnects using synchrotron nanodiffraction Appl. Phys. Lett. 124, 083501 (2024) https://doi.org/10.1063/5.0192672 open_in_new…
…researcher in a generation of scientists who deepened the understanding of the new materials that form the basis of our development towards a better and sustainable society. As a pioneer,…
…Sweden – is a new doctoral programme training the next generation of leading synchrotron experts. Please find detailed information on the Programme here. We are organising two online Recruitment Days…
…Sweden – is a new doctoral programme training the next generation of leading synchrotron experts. Please find detailed information on the Programme here. We are organising two online Recruitment Days…
…existing machines with new capabilities, related to the user research at beamlines. Please, feel free to answer this short questionnaire as it will allow us to gauge the user interest…
…and the know-how for advanced materials characterization. Read more about applying to ReMade@ARI to get access to this vast network of research facilities and take your research to new heights….
…scientists from industry and academia! You should be new to, or starting to work with, x-ray and neutron methods, and interested in studying food structure in the entire value chain,…
…(3 crystals) New data collected in July 2022 in collaboration with expert commissioning users. The Co Ka1 HERFD spectra were collected together with expert commissioning users (A. Jentys group from…
…Berzins. Publication Aljabbari A., Kihara S., Rades T., Boyd BJ., Berzins K. The Influence of Gastrointestinal Biomolecules on Solid-State Transformations in Pharmaceutical Particulates Mol Pharm. 7, 4297 (2023) 10.1021/acs.molpharmaceut.3c00442 open_in_new…